SKI Market

Indian Indices

Nifty

22,200.55 -17.30
(-0.08%)

Sensex

72,987.03 -117.58
( -0.16%)

Bank Nifty

47,687.45 -172.00
( -0.36%)

Nifty IT

33,117.40 -5.45
( -0.02%)

Global Indices

Nasdaq

16,511.18 122.94
(0.75%)

Dow Jones

39,558.11 126.60
(0.32%)

Hang Seng

19,073.71 -41.35
(-0.22%)

Nikkei 225

38,385.73 29.67
(0.08%)

Forex

USD-INR

83.51 -0.04
(-0.05%)

EUR-INR

90.06 0.08
(0.08%)

GBP-INR

104.74 0.11
(0.10%)

JPY-INR

0.54 0.00
(-0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Mindspace Business Parks REIT

Industry : Construction

BSE Code

ISIN Demat

Book Value()

543217

INE0CCU25019

280.7822848

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MINDSPACE

17.76

20586.03

EPS(TTM)

Face Value()

Div & Yield %

19.55

275

1.37

Back

Oxygenta Pharmaceutical reports standalone net loss of Rs 3.36 crore in the December 2023 quarter

Feb 15,2024

Net Loss of Oxygenta Pharmaceutical reported to Rs 3.36 crore in the quarter ended December 2023 as against net loss of Rs 3.25 crore during the previous quarter ended December 2022. Sales rose 16.56% to Rs 9.15 crore in the quarter ended December 2023 as against Rs 7.85 crore during the previous quarter ended December 2022.

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	9.15	7.85	17
OPM %	-27.10	-29.68	-
PBDT	-2.81	-2.51	-12
PBT	-3.50	-2.91	-20
NP	-3.36	-3.25	-3

22,200.55 -17.30 (-0.08%)

72,987.03 -117.58 ( -0.16%)

47,687.45 -172.00 ( -0.36%)

33,117.40 -5.45 ( -0.02%)

16,511.18 122.94 (0.75%)

39,558.11 126.60 (0.32%)

19,073.71 -41.35 (-0.22%)

38,385.73 29.67 (0.08%)

83.51 -0.04 (-0.05%)

90.06 0.08 (0.08%)

104.74 0.11 (0.10%)

0.54 0.00 (-0.16%)